Showing results (51-60 of 246) with videos related to

Sort By:
Pageof 25
The Hematology Journal : the Official Journal of the European Haematology Association|January 11, 2003
Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolismPer Svensson, Anna Södermark, Sam Schulman
Thrombosis and Haemostasis|April 4, 2023
Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart ReviewJohnathon Gorman, Matteo Candeloro, Sam Schulman
Thrombosis and Haemostasis|June 9, 2017
Venous thromboembolism: Past, present and futureSam Schulman, Walter Ageno, Stavros V Konstantinides
Thrombosis Journal|October 18, 2008
Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort studySam Schulman, Rajae Elbazi, Michelle Zondag, et al.
Journal of Thrombosis and Thrombolysis|November 25, 2017
Oral anticoagulant dosing, administration, and storage: a cross-sectional survey of Canadian health care providersSiavash Piran, Sam Schulman, Mohamed Panju, et al.
Thrombosis and Haemostasis|March 17, 2026
Safety of prothrombin complex concentrate for emergency surgery according to the oral factor Xa inhibitor levelAli Eshaghpour, Menaka Pai, Nicole Ibragimov, et al.
Expert Review of Hematology|November 30, 2017
Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trialsCristina Tarango, Sam Schulman, Marisol Betensky, et al.
British Journal of Hospital Medicine (London, England : 2005)|May 26, 2023
Antithrombotic therapy in the management of hospitalised patients with COVID-19Ioannis Koulas, Mark Goldin, Sam Schulman, et al.
Thrombosis and Haemostasis|December 22, 2010
A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgeryKarina Meijer, Yang-Ki Kim, Donna Carter, et al.
Seminars in Hematology|January 15, 2011
Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significanceSigurdur Yngvi Kristinsson, Magnus Björkholm, Sam Schulman, et al.
Pageof 25